# Siegfried Hameln GmbH, Hameln, Germany – FDA Inspections

Source: https://www.keypedia.com/companies/siegfried-hameln-gmbh/f6010d3b-48cd-40df-ad2f-b13fa57fca0b

> Inspection records and compliance data for Siegfried Hameln GmbH in Hameln. 6 FDA inspections on record (1 OAI), 1 Form 483, last inspected September 01, 2022.

---

## Details

- Name: Siegfried Hameln GmbH
- FEI Number: 3002807877
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: Langes Feld 13
- City: Hameln
- Country Name: Germany
- Address: Langes Feld 13, Hameln, Germany
- Country: Germany

## Related Documents

- FDA Inspection 1203347 - Siegfried Hameln GmbH - 2022-09-01 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 1, 2022
- [FDA Inspection 1050123 - Siegfried Hameln GmbH - 2018-04-24](https://www.keypedia.com/records/fda_inspections/siegfried-hameln-gmbh/e042aba9-c4b7-422c-b3eb-1a852022bb80) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 24, 2018
- FDA Inspection 1050123 - Siegfried Hameln GmbH - 2018-04-24 — classification: No Action Indicated (NAI), source: FDA, date: April 24, 2018
- FDA Inspection 987428 - Siegfried Hameln GmbH - 2016-07-01 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 1, 2016
- [FDA Inspection 887446 - Siegfried Hameln GmbH - 2014-07-25](https://www.keypedia.com/records/fda_inspections/siegfried-hameln-gmbh/098b0d0c-6d3f-4682-8290-157ece943b50) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 25, 2014
- [FDA Inspection 786813 - Siegfried Hameln GmbH - 2012-06-14](https://www.keypedia.com/records/fda_inspections/siegfried-hameln-gmbh/ee325421-5a50-4446-ab22-7f225fce421f) — classification: Official Action Indicated (OAI), source: FDA, date: June 14, 2012
- FDA Inspection 637807 - Siegfried Hameln GmbH - 2009-11-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 9, 2009

## Related Companies

- [GP Pharm SA](https://www.keypedia.com/companies/gp-pharm-sa/dc9c0e23-15fc-4984-99e1-68b6e5ad0899)
- [InfoRLife SA](https://www.keypedia.com/companies/inforlife-sa/41fbd76a-a030-4e8b-ace1-cc13b1dc52b1)
- [Patheon UK Limited](https://www.keypedia.com/companies/patheon-uk-limited/31ca8b94-243d-4f41-982b-56e0e11f0371)
- [Mylan Laboratories Limited](https://www.keypedia.com/companies/mylan-laboratories-limited/1a3cc4bb-fac0-4252-89c5-c4ed77ea95f3)
- [USV Private Limited](https://www.keypedia.com/companies/usv-private-limited/bd239224-e346-475f-b4e4-2f7e21e6ba60)
- [Baxter Healthcare Corporation](https://www.keypedia.com/companies/baxter-healthcare-corporation/0296844d-4369-423c-824a-f7d71344ec07)
- [Organon Heist](https://www.keypedia.com/companies/organon-heist/e737764b-560f-483a-be05-cec3a613c7fb)
- [Fresenius Medical Care de Mexico, SA de CV](https://www.keypedia.com/companies/fresenius-medical-care-de-mexico-sa-de-cv/a425662c-8722-4035-b4f4-5cf408ae88ac)
- [NextPharma OY](https://www.keypedia.com/companies/nextpharma-oy/5b55d776-23ac-485d-bcb8-0a0c74091608)
- [Patheon France S.A.S.](https://www.keypedia.com/companies/patheon-france-sas/094a2977-7468-4413-a434-d808d4e5b87c)